This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
LAVAL, Quebec, Jan. 7, 2013 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("
Neptune") (Nasdaq:NEPT) (TSX.NTB) will be holding a conference call on Thursday January 17 at 4:30pm ET. The call will focus on the presentation of the financial results for the third quarter ended November 30, 2012, and will also provide an opportunity to comment on the status of its previously disclosed action plan to resume operations and supply customers.
The conference call hosts will be Henri Harland, President & CEO and André Godin, CFO.
Conference call details will be provided shortly.
Management will accept questions related to the financial results and its operations by telephone during the Q&A period at the end of the presentation. Questions can also be forwarded in advance or during the presentation to
An archived recording of the conference call will be available on Neptune's website (
www.neptunebiotech.com ) shortly after the call.
The unaudited interim consolidated financial statements of Neptune as at and for the interim period ended November 30, 2012 and related MD&A will be made available on SEDAR at
www.sedar.com , on EDGAR at
www.sec.gov/edgar.shtml and on Neptune's website at
http://www.neptunebiotech.com within applicable delays prior to the conference call.
About Neptune Technologies & Bioressources Inc.
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids, or PUFAs. Neptune has a patented process of extracting oils from Antarctic krill, which omega-3 PUFAs are then principally sold as bulk oil to Neptune's distributors who commercialize them under their private label primarily in the U.S., European and Asian neutraceutical markets. Neptune's lead products, Neptune Krill Oil (NKO®) and ECOKRILL Oil (EKO™), generally come in capsule form and serve as a dietary supplement to consumers.